| The evolving role of PET-CT in the management of esophageal cancer. | |
| | |
MedLine Citation:
|
PMID: 19293768 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Esophageal cancer, although uncommon in the United States, has been increasing in frequency, and despite advances in therapy, the diagnosis still carries a poor prognosis. Many patients present with locally advanced disease and receive multimodality therapy with combined chemoradiation before surgery. Imaging plays an important role in the initial selection of patients for tri-modality therapy and in evaluating responses to neoadjuvant chemoradiation prior to surgery. There is increasing use of 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in management of esophageal cancer to identify distant metastasis at presentation and to assess response to therapy. Standardized imaging protocols with semiquantitative analysis may also provide prognostic information and be used to individualize patient therapy. This review will discuss the role of imaging studies in the management of esophageal cancer patients, with particular attention to FDG-PET/CT. |
| | |
Authors:
|
H H Chuang; H A Macapinlac |
Related Documents
:
|
19914978 - Pet/ct-guided percutaneous biopsy of isolated intramuscular metastases from postcricoid... 3672658 - Staging of bladder carcinoma by magnetic resonance imaging. a preliminary report. 19544378 - Revisiting the role of positron-emission tomography/computed tomography in determining ... 17564738 - Pet-ct in pediatric langerhans cell histiocytosis. 2398148 - Role of slice thickness in mr imaging of the internal auditory canal. 7665868 - Magnetic resonance imaging for the visualization of cholesterol gallstones in hamster f... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology Volume: 53 ISSN: 1824-4785 ISO Abbreviation: - Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-03-18 Completed Date: 2009-09-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101213861 Medline TA: Q J Nucl Med Mol Imaging Country: Italy |
Other Details:
|
Languages: eng Pagination: 201-9 Citation Subset: IM |
Affiliation:
|
Department of Nuclear Medicine, University of Texas M. D., Anderson Cancer Center, Houston, TX 77030, USA. chuanghh@mdanderson.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Esophageal Neoplasms
/
diagnosis*,
pathology,
therapy* Humans Neoplasm Staging Positron-Emission Tomography / methods* Tomography, X-Ray Computed / methods* Treatment Outcome |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.
Next Document: Breast cancer therapy: the role of PET-CT in decision making.